- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT01108796
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
Additional Effect of a Life Style Program on Antihypertensive Treatment With Telmisartan
This post-marketing surveillance study is designed to supplement the data on efficacy and tolerability of Micardis® and MicardisPlus® in patients at cardiovascular risk under general practice conditions.
The aim of the study is to investigate the effect of a six-month treatment with Micardis® / MicardisPlus® on blood pressure and the effect of the Lifestyle education tool for weight reduction on blood pressure control.
In addition, the post-marketing surveillance study will provide information on the effects on target measurement of the Lifestyle education tool and various laboratory parameters produced by treatment with Micardis® and MicardisPlus® in an unselected patient population under general practice conditions.
Обзор исследования
Статус
Условия
Тип исследования
Регистрация (Действительный)
Контакты и местонахождение
Места учебы
-
-
-
?adca, Словения
- Boehringer Ingelheim Investigational Site 34
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 2
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 3
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 4
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 5
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 6
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 7
-
Banská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 8
-
Bardejov, Словения
- Boehringer Ingelheim Investigational Site 10
-
Bardejov, Словения
- Boehringer Ingelheim Investigational Site 11
-
Bardejov, Словения
- Boehringer Ingelheim Investigational Site 12
-
Bardejov, Словения
- Boehringer Ingelheim Investigational Site 9
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 13
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 14
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 15
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 16
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 17
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 18
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 19
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 20
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 21
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 22
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 23
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 24
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 25
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 26
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 27
-
Bratislava, Словения
- Boehringer Ingelheim Investigational Site 28
-
Brezno, Словения
- Boehringer Ingelheim Investigational Site 29
-
Brezno, Словения
- Boehringer Ingelheim Investigational Site 30
-
Brezno, Словения
- Boehringer Ingelheim Investigational Site 31
-
Brezno, Словения
- Boehringer Ingelheim Investigational Site 32
-
Byt?a, Словения
- Boehringer Ingelheim Investigational Site 33
-
Bánovce nad Bebravou, Словения
- Boehringer Ingelheim Investigational Site 1
-
Dolný Kubín, Словения
- Boehringer Ingelheim Investigational Site 35
-
Dubnica nad Váhom, Словения
- Boehringer Ingelheim Investigational Site 36
-
Dubnica nad Váhom, Словения
- Boehringer Ingelheim Investigational Site 37
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 38
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 39
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 40
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 41
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 42
-
Dunajská Streda, Словения
- Boehringer Ingelheim Investigational Site 43
-
Galanta, Словения
- Boehringer Ingelheim Investigational Site 44
-
Galanta, Словения
- Boehringer Ingelheim Investigational Site 45
-
Handlová, Словения
- Boehringer Ingelheim Investigational Site 46
-
Hlohovec, Словения
- Boehringer Ingelheim Investigational Site 47
-
Hlohovec, Словения
- Boehringer Ingelheim Investigational Site 48
-
Hnús?a, Словения
- Boehringer Ingelheim Investigational Site 49
-
Hurbanovo, Словения
- Boehringer Ingelheim Investigational Site 50
-
Jesenské, Словения
- Boehringer Ingelheim Investigational Site 51
-
Kezmarok, Словения
- Boehringer Ingelheim Investigational Site 52
-
Kolárovo, Словения
- Boehringer Ingelheim Investigational Site 53
-
Komárno, Словения
- Boehringer Ingelheim Investigational Site 54
-
Komárno, Словения
- Boehringer Ingelheim Investigational Site 55
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 56
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 57
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 58
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 59
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 60
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 61
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 62
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 63
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 64
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 65
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 66
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 67
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 68
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 69
-
Kosice, Словения
- Boehringer Ingelheim Investigational Site 70
-
Krá?ovský Chlmec, Словения
- Boehringer Ingelheim Investigational Site 71
-
Kysucké Nové Mesto, Словения
- Boehringer Ingelheim Investigational Site 72
-
Kysucké Nové Mesto, Словения
- Boehringer Ingelheim Investigational Site 73
-
Kysucké Nové Mesto, Словения
- Boehringer Ingelheim Investigational Site 74
-
Levice, Словения
- Boehringer Ingelheim Investigational Site 75
-
Levice, Словения
- Boehringer Ingelheim Investigational Site 76
-
Levice, Словения
- Boehringer Ingelheim Investigational Site 77
-
Lipany, Словения
- Boehringer Ingelheim Investigational Site 78
-
Lu?enec, Словения
- Boehringer Ingelheim Investigational Site 79
-
Lu?enec, Словения
- Boehringer Ingelheim Investigational Site 80
-
Lu?enec, Словения
- Boehringer Ingelheim Investigational Site 81
-
Lu?enec, Словения
- Boehringer Ingelheim Investigational Site 82
-
Martin, Словения
- Boehringer Ingelheim Investigational Site 83
-
Martin, Словения
- Boehringer Ingelheim Investigational Site 84
-
Martin, Словения
- Boehringer Ingelheim Investigational Site 85
-
Michalovce, Словения
- Boehringer Ingelheim Investigational Site 86
-
Michalovce, Словения
- Boehringer Ingelheim Investigational Site 87
-
Michalovce, Словения
- Boehringer Ingelheim Investigational Site 88
-
Myjava, Словения
- Boehringer Ingelheim Investigational Site 89
-
Nitra, Словения
- Boehringer Ingelheim Investigational Site 91
-
Nitra, Словения
- Boehringer Ingelheim Investigational Site 92
-
Nitra, Словения
- Boehringer Ingelheim Investigational Site 93
-
Nitra, Словения
- Boehringer Ingelheim Investigational Site 94
-
Nové Mesto nad Váhom, Словения
- Boehringer Ingelheim Investigational Site 95
-
Nové Mesto nad Váhom, Словения
- Boehringer Ingelheim Investigational Site 96
-
Nové Mesto nad Váhom, Словения
- Boehringer Ingelheim Investigational Site 97
-
Nové Zámky, Словения
- Boehringer Ingelheim Investigational Site 100
-
Nové Zámky, Словения
- Boehringer Ingelheim Investigational Site 101
-
Nové Zámky, Словения
- Boehringer Ingelheim Investigational Site 98
-
Nové Zámky, Словения
- Boehringer Ingelheim Investigational Site 99
-
Námestovo, Словения
- Boehringer Ingelheim Investigational Site 90
-
Partizánske, Словения
- Boehringer Ingelheim Investigational Site 102
-
Partizánske, Словения
- Boehringer Ingelheim Investigational Site 103
-
Pezinok, Словения
- Boehringer Ingelheim Investigational Site 104
-
Pies?any, Словения
- Boehringer Ingelheim Investigational Site 105
-
Poprad, Словения
- Boehringer Ingelheim Investigational Site 106
-
Poprad, Словения
- Boehringer Ingelheim Investigational Site 107
-
Poprad, Словения
- Boehringer Ingelheim Investigational Site 108
-
Povazská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 109
-
Povazská Bystrica, Словения
- Boehringer Ingelheim Investigational Site 110
-
Presov, Словения
- Boehringer Ingelheim Investigational Site 111
-
Presov, Словения
- Boehringer Ingelheim Investigational Site 112
-
Presov, Словения
- Boehringer Ingelheim Investigational Site 113
-
Presov, Словения
- Boehringer Ingelheim Investigational Site 114
-
Prievidza, Словения
- Boehringer Ingelheim Investigational Site 115
-
Prievidza, Словения
- Boehringer Ingelheim Investigational Site 116
-
Prievidza, Словения
- Boehringer Ingelheim Investigational Site 117
-
Rajec, Словения
- Boehringer Ingelheim Investigational Site 118
-
Revúca, Словения
- Boehringer Ingelheim Investigational Site 119
-
Revúca, Словения
- Boehringer Ingelheim Investigational Site 120
-
Rimavská Sobota, Словения
- Boehringer Ingelheim Investigational Site 121
-
Rimavská Sobota, Словения
- Boehringer Ingelheim Investigational Site 122
-
Rimavská Sobota, Словения
- Boehringer Ingelheim Investigational Site 123
-
Roz?ava, Словения
- Boehringer Ingelheim Investigational Site 124
-
Roz?ava, Словения
- Boehringer Ingelheim Investigational Site 125
-
Ruzomberok, Словения
- Boehringer Ingelheim Investigational Site 126
-
Ruzomberok, Словения
- Boehringer Ingelheim Investigational Site 127
-
Sa?a, Словения
- Boehringer Ingelheim Investigational Site 128
-
Sa?a, Словения
- Boehringer Ingelheim Investigational Site 129
-
Sa?a, Словения
- Boehringer Ingelheim Investigational Site 130
-
Se?ovce, Словения
- Boehringer Ingelheim Investigational Site 131
-
Se?ovce, Словения
- Boehringer Ingelheim Investigational Site 132
-
Skalica, Словения
- Boehringer Ingelheim Investigational Site 133
-
Snina, Словения
- Boehringer Ingelheim Investigational Site 134
-
Snina, Словения
- Boehringer Ingelheim Investigational Site 135
-
Spisská Nová Ves, Словения
- Boehringer Ingelheim Investigational Site 136
-
Spisská Nová Ves, Словения
- Boehringer Ingelheim Investigational Site 137
-
Stará ?ubov?a, Словения
- Boehringer Ingelheim Investigational Site 138
-
Stará ?ubov?a, Словения
- Boehringer Ingelheim Investigational Site 139
-
Stará ?ubov?a, Словения
- Boehringer Ingelheim Investigational Site 140
-
Stropkov, Словения
- Boehringer Ingelheim Investigational Site 141
-
Stúrovo, Словения
- Boehringer Ingelheim Investigational Site 142
-
Surany, Словения
- Boehringer Ingelheim Investigational Site 143
-
Surany, Словения
- Boehringer Ingelheim Investigational Site 144
-
Svit, Словения
- Boehringer Ingelheim Investigational Site 145
-
Topo??any, Словения
- Boehringer Ingelheim Investigational Site 146
-
Torna?a, Словения
- Boehringer Ingelheim Investigational Site 147
-
Trebisov, Словения
- Boehringer Ingelheim Investigational Site 148
-
Trebisov, Словения
- Boehringer Ingelheim Investigational Site 149
-
Trebisov, Словения
- Boehringer Ingelheim Investigational Site 150
-
Tren?ín, Словения
- Boehringer Ingelheim Investigational Site 151
-
Tren?ín, Словения
- Boehringer Ingelheim Investigational Site 152
-
Tren?ín, Словения
- Boehringer Ingelheim Investigational Site 153
-
Tren?ín, Словения
- Boehringer Ingelheim Investigational Site 154
-
Trnava, Словения
- Boehringer Ingelheim Investigational Site 155
-
Trnava, Словения
- Boehringer Ingelheim Investigational Site 156
-
Trnava, Словения
- Boehringer Ingelheim Investigational Site 157
-
Trnava, Словения
- Boehringer Ingelheim Investigational Site 158
-
Trstená, Словения
- Boehringer Ingelheim Investigational Site 159
-
Tur?ianske Teplice, Словения
- Boehringer Ingelheim Investigational Site 160
-
Turzovka, Словения
- Boehringer Ingelheim Investigational Site 161
-
Ve?ké Kapusany, Словения
- Boehringer Ingelheim Investigational Site 162
-
Ve?ké Kapusany, Словения
- Boehringer Ingelheim Investigational Site 163
-
Ve?ký Krtís, Словения
- Boehringer Ingelheim Investigational Site 164
-
Ve?ký Krtís, Словения
- Boehringer Ingelheim Investigational Site 165
-
Vranov nad Top?ou, Словения
- Boehringer Ingelheim Investigational Site 167
-
Vráble, Словения
- Boehringer Ingelheim Investigational Site 166
-
Zarnovica, Словения
- Boehringer Ingelheim Investigational Site 168
-
Zeliezovce, Словения
- Boehringer Ingelheim Investigational Site 169
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 170
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 171
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 172
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 173
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 174
-
Zilina, Словения
- Boehringer Ingelheim Investigational Site 175
-
Zlaté Moravce, Словения
- Boehringer Ingelheim Investigational Site 176
-
Zlaté Moravce, Словения
- Boehringer Ingelheim Investigational Site 177
-
Zlaté Moravce, Словения
- Boehringer Ingelheim Investigational Site 178
-
Zvolen, Словения
- Boehringer Ingelheim Investigational Site 179
-
Zvolen, Словения
- Boehringer Ingelheim Investigational Site 180
-
Zvolen, Словения
- Boehringer Ingelheim Investigational Site 181
-
Zvolen, Словения
- Boehringer Ingelheim Investigational Site 182
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Метод выборки
Исследуемая популяция
Описание
Inclusion criteria:
- Patients with essential hypertension (blood pressure (BP) higher or equal to 140/90 mmHg or higher or equal to 130/80 mmHg in case of diabetic patients)
- Patients with hypertension under treatment with one or more antihypertensive drug
Exclusion criteria:
Patients are excluded according to the summary of product characteristics (SmPC).
Учебный план
Как устроено исследование?
Детали дизайна
Когорты и вмешательства
Группа / когорта |
|---|
|
Patients at cardiovascular risk
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Changes in Mean Blood Pressure (Systolic) After Treatment, Compared to Baseline
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in blood pressure in patients with systolic values, measured at baseline and final visit, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
|
Changes in Mean Blood Pressure (Diastolic) After Treatment, Compared to Baseline
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in blood pressure in patients with diastolic values, measured at baseline and final visit, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Changes in Laboratory Parameters:Low Density Lipoprotein (LDL)
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
|
Changes in Laboratory Parameters:High Density Lipoprotein (HDL)
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
|
Changes in Laboratory Parameters: Triglycerides
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in the triglyceride levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
|
Changes in Laboratory Parameters: Blood Glucose
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Changes in the fasting blood glucose levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
|
24 weeks (Visit 1 to Visit 3)
|
|
Assessment of Metabolic Effect
Временное ограничение: 24 weeks (Visit 1 to Visit 3)
|
Metabolic effect was rated by the investigators as 'positive', 'neutral' and 'negative'
|
24 weeks (Visit 1 to Visit 3)
|
Соавторы и исследователи
Спонсор
Публикации и полезные ссылки
Полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 502.579
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .